Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Valneva SE (VALN) Operating Expenses (2021 - 2026)

Valneva SE (VALN) posted Operating Expenses of -$22.5 million for Q1 2026, down 108.93% sequentially from $251.6 million in Q4 2025, and down 8.29% YoY from -$24.5 million in Q1 2025.

Analysis

Valneva SE (VALN) Operating Expenses (2021 - 2026) Analysis & Trends

Valneva SE has reported Operating Expenses for 6 years, with the latest figure at -$22.5 million in Q1 2026.

  • Quarterly Operating Expenses fell 8.29% year-over-year to -$22.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $163.5 million (up 15.37% YoY) and the FY2025 annual result came in at $162.4 million, up 14.03% from the prior year.
  • Operating Expenses eased to -$22.5 million in Q1 2026 per VALN's latest filing, from $251.6 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $10.6 billion in Q3 2022 and troughed at -$10.5 billion in Q4 2022.
  • A 5-year average of $25.1 million and a median of -$23.9 million in 2023 frame the typical range for Operating Expenses.
  • The widest YoY moves for Operating Expenses: up 18399.42% in 2022, down 2591.22% in 2022.
  • Over 5 years, Operating Expenses stood at -$10.5 billion in 2022, then soared by 101.92% to $202.7 million in 2023, then increased by 6.51% to $215.9 million in 2024, then climbed by 16.57% to $251.6 million in 2025, then slumped by 108.93% to -$22.5 million in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods registered -$22.5 million, $251.6 million, and -$39.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 2.09 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 3.00 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -1.05 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 960.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 505.13 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.21 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.06 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 541.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 427.03 Mn
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn -21.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -21.84 Mn
Mar 31, 2026 -22.46 Mn
Dec 31, 2025 -33.84 Mn
Sep 30, 2025 -39.25 Mn
Jun 30, 2025 -26.44 Mn
Mar 31, 2025 -20.74 Mn
Dec 31, 2024 -33.95 Mn
Sep 30, 2024 -27.36 Mn
Jun 30, 2024 -26.07 Mn
Mar 31, 2024 -23.14 Mn
Dec 31, 2023 -29.06 Mn
Sep 30, 2023 -27.62 Mn
Jun 30, 2023 -23.97 Mn
Mar 31, 2023 -23.08 Mn
Dec 31, 2022 -10.82 Bn
Sep 30, 2022 10.63 Bn
Jun 30, 2022 -39.86 Mn
Mar 31, 2022 -25.66 Mn
Dec 31, 2021 -82.36 Mn
Sep 30, 2021 -58.09 Mn